Clinical Trial Update: Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART [Phase 4]

View source ↗

Summary

Phase 4 trial examining immune reconstitution and reduced immune activation with darunavir-based ART in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• darunavir-based antiretroviral therapy (darunavir)

Snippet

Sponsor: University of California, Davis | Conditions: Human Immunodeficiency Virus Infection | Phase 4 | Status: COMPLETED | Results posted: 2020-03-04